Larry Gold
Concepts (331)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aptamers, Nucleotide | 10 | 2024 | 78 | 2.300 |
Why?
| RNA | 24 | 2020 | 883 | 1.860 |
Why?
| SELEX Aptamer Technique | 7 | 2016 | 14 | 1.360 |
Why?
| Proteomics | 12 | 2024 | 1010 | 1.310 |
Why?
| T-Phages | 15 | 1991 | 18 | 1.170 |
Why?
| Nucleic Acid Conformation | 33 | 2000 | 706 | 1.080 |
Why?
| RNA, Catalytic | 4 | 2020 | 185 | 1.070 |
Why?
| Base Sequence | 53 | 2003 | 2135 | 1.060 |
Why?
| Escherichia coli | 23 | 1997 | 771 | 1.010 |
Why?
| Molecular Sequence Data | 53 | 2012 | 2819 | 1.000 |
Why?
| Proteome | 7 | 2024 | 431 | 0.810 |
Why?
| Oligoribonucleotides | 10 | 1997 | 52 | 0.790 |
Why?
| Viral Proteins | 14 | 1997 | 321 | 0.770 |
Why?
| DNA, Single-Stranded | 7 | 2003 | 114 | 0.730 |
Why?
| Ligands | 22 | 2016 | 614 | 0.720 |
Why?
| Ribonucleotides | 1 | 2020 | 24 | 0.680 |
Why?
| Biomarkers | 9 | 2015 | 3896 | 0.680 |
Why?
| RNA, Messenger | 15 | 2000 | 2676 | 0.670 |
Why?
| Ribosomes | 12 | 1995 | 164 | 0.670 |
Why?
| Oligodeoxyribonucleotides | 8 | 2003 | 138 | 0.630 |
Why?
| Reverse Transcriptase Inhibitors | 6 | 1996 | 81 | 0.610 |
Why?
| Proteins | 9 | 2014 | 936 | 0.580 |
Why?
| Genes, Viral | 11 | 1995 | 81 | 0.540 |
Why?
| Peptide Chain Initiation, Translational | 6 | 1995 | 42 | 0.510 |
Why?
| Protein Biosynthesis | 10 | 1997 | 397 | 0.510 |
Why?
| Binding Sites | 23 | 2000 | 1241 | 0.490 |
Why?
| Blood Proteins | 3 | 2015 | 240 | 0.480 |
Why?
| RNA, Viral | 10 | 2000 | 617 | 0.470 |
Why?
| HIV-1 | 8 | 1996 | 842 | 0.460 |
Why?
| Oligonucleotides | 4 | 2011 | 138 | 0.450 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2015 | 94 | 0.450 |
Why?
| Q beta Replicase | 4 | 1996 | 4 | 0.420 |
Why?
| RNA, Ribosomal | 1 | 2014 | 162 | 0.420 |
Why?
| Diagnosis | 2 | 2013 | 11 | 0.400 |
Why?
| DNA | 4 | 2011 | 1392 | 0.400 |
Why?
| Capsid | 3 | 2000 | 91 | 0.400 |
Why?
| Bacteriophage T4 | 4 | 1997 | 15 | 0.390 |
Why?
| Kinetics | 14 | 2010 | 1617 | 0.340 |
Why?
| Polymerase Chain Reaction | 15 | 2000 | 1021 | 0.340 |
Why?
| Gene Products, rev | 2 | 2002 | 6 | 0.330 |
Why?
| HIV Reverse Transcriptase | 5 | 1996 | 30 | 0.330 |
Why?
| Protein Binding | 13 | 2014 | 2106 | 0.320 |
Why?
| DNA-Directed DNA Polymerase | 3 | 1997 | 43 | 0.310 |
Why?
| History, 20th Century | 3 | 2015 | 292 | 0.300 |
Why?
| Capsid Proteins | 2 | 2000 | 91 | 0.290 |
Why?
| Evolution, Molecular | 4 | 2020 | 467 | 0.290 |
Why?
| Information Systems | 3 | 1998 | 62 | 0.290 |
Why?
| RNA, Bacterial | 4 | 2000 | 182 | 0.290 |
Why?
| Bacterial Proteins | 4 | 1996 | 826 | 0.290 |
Why?
| Biological Evolution | 5 | 2014 | 426 | 0.290 |
Why?
| RNA-Binding Proteins | 4 | 2000 | 388 | 0.270 |
Why?
| RNA, Transfer | 4 | 1991 | 130 | 0.260 |
Why?
| RNA Processing, Post-Transcriptional | 4 | 1996 | 87 | 0.260 |
Why?
| Directed Molecular Evolution | 2 | 1996 | 26 | 0.260 |
Why?
| DNA Primers | 10 | 2012 | 510 | 0.260 |
Why?
| DNA-Binding Proteins | 5 | 1993 | 1423 | 0.250 |
Why?
| Bacteriophages | 2 | 2000 | 92 | 0.250 |
Why?
| RNA-Directed DNA Polymerase | 5 | 1996 | 34 | 0.240 |
Why?
| Protein Array Analysis | 3 | 2014 | 56 | 0.240 |
Why?
| Gene Library | 2 | 2010 | 116 | 0.230 |
Why?
| Clinical Laboratory Techniques | 2 | 2003 | 94 | 0.230 |
Why?
| Cloning, Molecular | 11 | 1998 | 522 | 0.230 |
Why?
| Tenascin | 1 | 2003 | 13 | 0.220 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 757 | 0.220 |
Why?
| Templates, Genetic | 6 | 2003 | 61 | 0.210 |
Why?
| Amino Acid Sequence | 9 | 2003 | 2041 | 0.200 |
Why?
| Peptide Initiation Factors | 3 | 1993 | 17 | 0.200 |
Why?
| DNA, Bacterial | 5 | 1997 | 324 | 0.200 |
Why?
| Biomarkers, Tumor | 3 | 2012 | 1185 | 0.200 |
Why?
| Codon | 7 | 1994 | 86 | 0.190 |
Why?
| Drug Evaluation, Preclinical | 1 | 2002 | 168 | 0.190 |
Why?
| Plasmids | 6 | 1992 | 357 | 0.190 |
Why?
| Protein Interaction Mapping | 1 | 2002 | 109 | 0.190 |
Why?
| Bacteriophage lambda | 3 | 1992 | 88 | 0.180 |
Why?
| Genomic Library | 2 | 2000 | 15 | 0.180 |
Why?
| Antibodies | 3 | 2014 | 391 | 0.170 |
Why?
| Reproducibility of Results | 5 | 2024 | 3033 | 0.170 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2000 | 15 | 0.170 |
Why?
| Aptamers, Peptide | 2 | 2011 | 3 | 0.170 |
Why?
| Substrate Specificity | 6 | 2000 | 367 | 0.170 |
Why?
| Neoplasm Proteins | 1 | 2003 | 421 | 0.160 |
Why?
| Genome, Bacterial | 1 | 2000 | 134 | 0.160 |
Why?
| Gene Expression Regulation | 6 | 2002 | 2508 | 0.160 |
Why?
| Structure-Activity Relationship | 7 | 2002 | 531 | 0.160 |
Why?
| Nucleic Acids | 2 | 2011 | 60 | 0.150 |
Why?
| Recombinant Proteins | 7 | 2014 | 1284 | 0.150 |
Why?
| Humans | 29 | 2024 | 129116 | 0.150 |
Why?
| Mass Spectrometry | 4 | 2010 | 660 | 0.150 |
Why?
| Computer Simulation | 3 | 1998 | 941 | 0.150 |
Why?
| Antiviral Agents | 2 | 1995 | 706 | 0.150 |
Why?
| Chloramphenicol | 1 | 1997 | 9 | 0.150 |
Why?
| Peptidyl Transferases | 1 | 1997 | 7 | 0.150 |
Why?
| Erythrocyte Membrane | 1 | 1998 | 49 | 0.150 |
Why?
| Ribosomal Proteins | 2 | 1995 | 77 | 0.140 |
Why?
| S-Adenosylmethionine | 1 | 1997 | 52 | 0.140 |
Why?
| DNA, Viral | 4 | 1993 | 348 | 0.140 |
Why?
| Binding, Competitive | 5 | 1996 | 199 | 0.140 |
Why?
| Guanosine Monophosphate | 1 | 1996 | 7 | 0.140 |
Why?
| Gene Products, gag | 1 | 1996 | 36 | 0.130 |
Why?
| Bradykinin | 1 | 1996 | 45 | 0.130 |
Why?
| Molecular Biology | 1 | 1997 | 55 | 0.130 |
Why?
| Repressor Proteins | 3 | 1996 | 400 | 0.130 |
Why?
| Models, Molecular | 4 | 2012 | 1483 | 0.130 |
Why?
| Nucleic Acid Hybridization | 2 | 2010 | 188 | 0.130 |
Why?
| DNA Replication | 3 | 1993 | 225 | 0.130 |
Why?
| DNA Nucleotidyltransferases | 1 | 1995 | 11 | 0.120 |
Why?
| RNA, Antisense | 2 | 1992 | 15 | 0.120 |
Why?
| Endoribonucleases | 1 | 1996 | 70 | 0.120 |
Why?
| Base Composition | 4 | 1996 | 75 | 0.120 |
Why?
| Adenosine | 1 | 1997 | 211 | 0.120 |
Why?
| Nerve Growth Factors | 1 | 1995 | 73 | 0.120 |
Why?
| Substance P | 1 | 1995 | 43 | 0.120 |
Why?
| Eye Diseases | 1 | 2016 | 79 | 0.120 |
Why?
| Ribonucleases | 1 | 1994 | 54 | 0.120 |
Why?
| Ophthalmology | 1 | 2016 | 82 | 0.120 |
Why?
| Consensus Sequence | 5 | 2000 | 72 | 0.110 |
Why?
| Transcription, Genetic | 5 | 2000 | 1403 | 0.110 |
Why?
| Models, Theoretical | 1 | 1998 | 546 | 0.110 |
Why?
| Origin of Life | 1 | 2014 | 8 | 0.110 |
Why?
| RNA, Transfer, Amino Acid-Specific | 1 | 1994 | 4 | 0.110 |
Why?
| Selenocysteine | 1 | 1994 | 3 | 0.110 |
Why?
| RNA, Transfer, Amino Acyl | 1 | 1994 | 9 | 0.110 |
Why?
| Escherichia coli Proteins | 1 | 1996 | 177 | 0.110 |
Why?
| Hydrolysis | 4 | 1997 | 185 | 0.110 |
Why?
| Peptide Elongation Factors | 1 | 1994 | 15 | 0.110 |
Why?
| Enzyme Inhibitors | 1 | 1997 | 811 | 0.110 |
Why?
| Genetic Techniques | 2 | 2010 | 64 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 816 | 0.110 |
Why?
| Genetic Vectors | 2 | 1992 | 311 | 0.110 |
Why?
| Operator Regions, Genetic | 2 | 1990 | 7 | 0.110 |
Why?
| Catalysis | 3 | 2002 | 305 | 0.110 |
Why?
| Sensitivity and Specificity | 4 | 2010 | 1825 | 0.110 |
Why?
| History, 21st Century | 1 | 2014 | 180 | 0.100 |
Why?
| Models, Genetic | 3 | 1991 | 591 | 0.100 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 34 | 0.100 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2012 | 1046 | 0.100 |
Why?
| Drug Therapy | 1 | 2013 | 76 | 0.100 |
Why?
| Genes, pX | 1 | 1992 | 2 | 0.100 |
Why?
| Deoxyribonuclease EcoRI | 1 | 1992 | 4 | 0.100 |
Why?
| Case-Control Studies | 3 | 2015 | 3342 | 0.100 |
Why?
| Body Fluids | 1 | 2012 | 62 | 0.100 |
Why?
| Affinity Labels | 2 | 2014 | 25 | 0.100 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 185 | 0.100 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 1993 | 323 | 0.100 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2011 | 17 | 0.090 |
Why?
| Mutation | 7 | 1995 | 3700 | 0.090 |
Why?
| Ribonucleotide Reductases | 1 | 1991 | 22 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 4 | 1995 | 150 | 0.090 |
Why?
| RNA, Ribosomal, 16S | 1 | 1993 | 521 | 0.090 |
Why?
| Biological Assay | 1 | 2011 | 118 | 0.090 |
Why?
| DNA Transposable Elements | 1 | 1992 | 119 | 0.090 |
Why?
| Chromosome Deletion | 1 | 1991 | 102 | 0.090 |
Why?
| Transcription Factors | 2 | 1989 | 1632 | 0.090 |
Why?
| Introns | 1 | 1991 | 249 | 0.090 |
Why?
| Animals | 7 | 2014 | 34600 | 0.080 |
Why?
| Anti-HIV Agents | 1 | 1996 | 748 | 0.080 |
Why?
| Genes, Regulator | 1 | 1989 | 33 | 0.080 |
Why?
| Promoter Regions, Genetic | 3 | 1991 | 1200 | 0.080 |
Why?
| Neoplasms | 2 | 2012 | 2475 | 0.080 |
Why?
| Micrococcal Nuclease | 1 | 1989 | 22 | 0.080 |
Why?
| Databases, Protein | 1 | 2009 | 61 | 0.080 |
Why?
| Exodeoxyribonucleases | 1 | 1988 | 24 | 0.080 |
Why?
| Lung Neoplasms | 2 | 2012 | 2329 | 0.080 |
Why?
| Metalloproteins | 1 | 1987 | 6 | 0.070 |
Why?
| Trans-Activators | 1 | 1990 | 381 | 0.070 |
Why?
| Cohort Studies | 2 | 2015 | 5407 | 0.070 |
Why?
| Computational Biology | 2 | 2003 | 598 | 0.070 |
Why?
| Avian Myeloblastosis Virus | 3 | 1996 | 4 | 0.070 |
Why?
| Societies | 1 | 2007 | 36 | 0.070 |
Why?
| Glomerular Filtration Rate | 1 | 2010 | 682 | 0.070 |
Why?
| Genes, Bacterial | 2 | 2000 | 158 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 3 | 2004 | 538 | 0.070 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 718 | 0.070 |
Why?
| Oligonucleotide Probes | 3 | 1991 | 50 | 0.070 |
Why?
| Early Detection of Cancer | 1 | 2010 | 372 | 0.070 |
Why?
| Sequence Analysis | 2 | 1996 | 38 | 0.070 |
Why?
| Peptide Fragments | 2 | 2003 | 686 | 0.060 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 1353 | 0.060 |
Why?
| Conserved Sequence | 2 | 1997 | 228 | 0.060 |
Why?
| Kidney Failure, Chronic | 1 | 2010 | 535 | 0.060 |
Why?
| Mathematics | 2 | 1998 | 103 | 0.060 |
Why?
| Membrane Proteins | 2 | 2003 | 1109 | 0.060 |
Why?
| Zinc | 1 | 1987 | 293 | 0.060 |
Why?
| Macromolecular Substances | 2 | 1996 | 211 | 0.060 |
Why?
| Models, Biological | 1 | 1991 | 1695 | 0.060 |
Why?
| DNA, Fungal | 2 | 1997 | 74 | 0.060 |
Why?
| RNA, Transfer, Met | 2 | 1994 | 6 | 0.060 |
Why?
| Selection, Genetic | 2 | 1998 | 250 | 0.050 |
Why?
| Molecular Structure | 2 | 2012 | 466 | 0.050 |
Why?
| Hydrogen Bonding | 2 | 1994 | 149 | 0.050 |
Why?
| beta-Galactosidase | 3 | 1994 | 75 | 0.050 |
Why?
| Restriction Mapping | 2 | 1995 | 74 | 0.050 |
Why?
| United States | 2 | 2015 | 13938 | 0.050 |
Why?
| Ultraviolet Rays | 2 | 1996 | 384 | 0.050 |
Why?
| Human Genome Project | 1 | 2003 | 15 | 0.050 |
Why?
| Drug Design | 2 | 1995 | 155 | 0.050 |
Why?
| Isomerism | 2 | 1992 | 48 | 0.050 |
Why?
| Education, Continuing | 1 | 2003 | 38 | 0.050 |
Why?
| Adenosine Triphosphate | 2 | 1997 | 471 | 0.050 |
Why?
| Gene Expression | 3 | 1992 | 1462 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2003 | 375 | 0.050 |
Why?
| Tumor Cells, Cultured | 1 | 2003 | 930 | 0.050 |
Why?
| Molecular Diagnostic Techniques | 2 | 2014 | 97 | 0.050 |
Why?
| Sequence Analysis, DNA | 2 | 2012 | 773 | 0.050 |
Why?
| Cross-Linking Reagents | 2 | 2004 | 206 | 0.040 |
Why?
| RNA, Fungal | 2 | 1991 | 67 | 0.040 |
Why?
| Child, Preschool | 1 | 2015 | 10450 | 0.040 |
Why?
| Prokaryotic Initiation Factor-3 | 2 | 1990 | 6 | 0.040 |
Why?
| Genome | 1 | 2002 | 277 | 0.040 |
Why?
| Glioblastoma | 1 | 2003 | 322 | 0.040 |
Why?
| In Vitro Techniques | 2 | 1995 | 1044 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 124 | 0.040 |
Why?
| Saccharomyces cerevisiae | 2 | 1997 | 525 | 0.040 |
Why?
| Machine Learning | 1 | 2024 | 447 | 0.040 |
Why?
| Young Adult | 1 | 2015 | 12389 | 0.040 |
Why?
| Male | 3 | 2015 | 63194 | 0.040 |
Why?
| RNA, Ribosomal, 23S | 1 | 1997 | 13 | 0.040 |
Why?
| DNA Mutational Analysis | 2 | 1990 | 386 | 0.040 |
Why?
| Genomics | 1 | 2003 | 716 | 0.040 |
Why?
| International Cooperation | 2 | 2009 | 173 | 0.040 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 1996 | 12 | 0.030 |
Why?
| Peptide Elongation Factor Tu | 1 | 1996 | 5 | 0.030 |
Why?
| Butanones | 1 | 1996 | 3 | 0.030 |
Why?
| Uridine Triphosphate | 1 | 1996 | 12 | 0.030 |
Why?
| Alkylation | 1 | 1996 | 24 | 0.030 |
Why?
| Replicon | 1 | 1996 | 14 | 0.030 |
Why?
| Thionucleotides | 1 | 1996 | 34 | 0.030 |
Why?
| NAD | 1 | 1997 | 71 | 0.030 |
Why?
| Metals | 1 | 1997 | 127 | 0.030 |
Why?
| Sulfur | 1 | 1996 | 50 | 0.030 |
Why?
| Gene Dosage | 1 | 1997 | 142 | 0.030 |
Why?
| rev Gene Products, Human Immunodeficiency Virus | 1 | 1995 | 6 | 0.030 |
Why?
| Adolescent | 1 | 2015 | 20301 | 0.030 |
Why?
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.030 |
Why?
| Neoplasm Metastasis | 2 | 2012 | 616 | 0.030 |
Why?
| Immunodeficiency Virus, Feline | 1 | 1996 | 33 | 0.030 |
Why?
| Buffers | 1 | 1995 | 55 | 0.030 |
Why?
| Aldehydes | 1 | 1996 | 138 | 0.030 |
Why?
| Mammary Tumor Virus, Mouse | 1 | 1995 | 43 | 0.030 |
Why?
| Viral Structural Proteins | 1 | 1995 | 12 | 0.030 |
Why?
| Viruses | 1 | 1996 | 99 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1997 | 508 | 0.030 |
Why?
| Child | 1 | 2015 | 20805 | 0.030 |
Why?
| Sepharose | 1 | 1995 | 31 | 0.030 |
Why?
| Virus Integration | 1 | 1995 | 69 | 0.030 |
Why?
| Aged | 2 | 2012 | 22083 | 0.030 |
Why?
| Arginine | 1 | 1996 | 259 | 0.030 |
Why?
| Sodium Chloride | 1 | 1995 | 138 | 0.030 |
Why?
| Enzyme Induction | 1 | 1994 | 89 | 0.030 |
Why?
| Ribonuclease H | 1 | 1994 | 12 | 0.030 |
Why?
| Leukemia Virus, Murine | 1 | 1994 | 17 | 0.030 |
Why?
| Integrases | 1 | 1995 | 118 | 0.030 |
Why?
| Selenoproteins | 1 | 1994 | 7 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 1994 | 18 | 0.030 |
Why?
| RNA, Transfer, Phe | 1 | 1993 | 9 | 0.030 |
Why?
| DNA, Complementary | 1 | 1994 | 267 | 0.030 |
Why?
| Models, Structural | 1 | 1993 | 40 | 0.030 |
Why?
| Software | 1 | 1998 | 610 | 0.030 |
Why?
| Rho Factor | 1 | 1993 | 3 | 0.030 |
Why?
| Electrophoresis | 1 | 1992 | 30 | 0.030 |
Why?
| Chromatography, Affinity | 1 | 1993 | 83 | 0.030 |
Why?
| Transition Temperature | 1 | 2012 | 27 | 0.030 |
Why?
| Middle Aged | 2 | 2012 | 31074 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 358 | 0.030 |
Why?
| Allosteric Regulation | 1 | 1992 | 99 | 0.030 |
Why?
| RNA, Small Untranslated | 1 | 2012 | 15 | 0.030 |
Why?
| Adult | 1 | 2015 | 35510 | 0.020 |
Why?
| Lac Operon | 1 | 1992 | 45 | 0.020 |
Why?
| Complement Inactivating Agents | 1 | 2013 | 45 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2012 | 209 | 0.020 |
Why?
| Titrimetry | 1 | 2011 | 10 | 0.020 |
Why?
| Random Allocation | 1 | 1992 | 346 | 0.020 |
Why?
| Limit of Detection | 1 | 2011 | 55 | 0.020 |
Why?
| Automation | 1 | 2011 | 80 | 0.020 |
Why?
| Ion Channels | 1 | 1992 | 127 | 0.020 |
Why?
| Sequence Analysis, RNA | 1 | 1994 | 428 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 1992 | 142 | 0.020 |
Why?
| Nanotechnology | 1 | 2012 | 119 | 0.020 |
Why?
| Anticodon | 1 | 1991 | 24 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2012 | 434 | 0.020 |
Why?
| Triticum | 1 | 1990 | 11 | 0.020 |
Why?
| Endodeoxyribonucleases | 1 | 1991 | 67 | 0.020 |
Why?
| Sequence Alignment | 1 | 1991 | 330 | 0.020 |
Why?
| Recombination, Genetic | 1 | 1991 | 189 | 0.020 |
Why?
| Placenta | 1 | 1997 | 716 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2012 | 480 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1992 | 335 | 0.020 |
Why?
| Gene Expression Regulation, Viral | 1 | 1990 | 86 | 0.020 |
Why?
| Germany | 1 | 1990 | 99 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2012 | 291 | 0.020 |
Why?
| Databases, Factual | 1 | 1995 | 1279 | 0.020 |
Why?
| Complement System Proteins | 1 | 2013 | 307 | 0.020 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 1989 | 22 | 0.020 |
Why?
| Nervous System Diseases | 1 | 2012 | 254 | 0.020 |
Why?
| Database Management Systems | 1 | 2009 | 48 | 0.020 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1989 | 87 | 0.020 |
Why?
| Open Reading Frames | 1 | 1989 | 116 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 1992 | 634 | 0.020 |
Why?
| Exodeoxyribonuclease V | 1 | 1988 | 6 | 0.020 |
Why?
| Genes | 1 | 1988 | 226 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 1687 | 0.020 |
Why?
| RNA Caps | 1 | 1988 | 31 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 1987 | 63 | 0.020 |
Why?
| Terminology as Topic | 1 | 2009 | 200 | 0.020 |
Why?
| Gene Conversion | 1 | 1987 | 6 | 0.020 |
Why?
| Female | 2 | 2012 | 68510 | 0.020 |
Why?
| Models, Statistical | 1 | 2010 | 626 | 0.020 |
Why?
| Europe | 1 | 2007 | 362 | 0.020 |
Why?
| Genetic Variation | 1 | 2010 | 934 | 0.020 |
Why?
| Virus Replication | 1 | 1987 | 444 | 0.010 |
Why?
| Endostatins | 1 | 2004 | 10 | 0.010 |
Why?
| Interleukin-16 | 1 | 2004 | 6 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 1991 | 1359 | 0.010 |
Why?
| Lod Score | 1 | 2004 | 66 | 0.010 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 25 | 0.010 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2004 | 85 | 0.010 |
Why?
| Carrier Proteins | 1 | 1987 | 732 | 0.010 |
Why?
| Smoking | 1 | 2010 | 1466 | 0.010 |
Why?
| Apoptosis | 1 | 2012 | 2438 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1621 | 0.010 |
Why?
| Autoantibodies | 1 | 2010 | 1465 | 0.010 |
Why?
| Colonic Neoplasms | 1 | 2004 | 242 | 0.010 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2004 | 501 | 0.010 |
Why?
| Light | 1 | 2004 | 355 | 0.010 |
Why?
| Inflammation | 1 | 2012 | 2668 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 1945 | 0.010 |
Why?
| Moloney murine leukemia virus | 1 | 1996 | 12 | 0.010 |
Why?
| Zidovudine | 1 | 1996 | 77 | 0.010 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 111 | 0.010 |
Why?
| Cats | 1 | 1996 | 210 | 0.010 |
Why?
| Virion | 1 | 1996 | 85 | 0.010 |
Why?
|
|
Gold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|